Gastrointestinal Cancer

Gastrointestinal Cancer

45 items identified
ABBV-400 for Advanced Solid Tumors
Alliance A021502 (Colon Cancer)
Alliance A021806
AMG 510 for colorectal or non-small-cell lung cancer with KRAS p.G12C mutation
AMG 510 in Advanced Solid Tumors With KRAS p.G12C Mutation
ARC-21 (Gastrointestinal Cancer)
CGX1321-101 (Gastrointestinal Cancer)
Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer
COLOMATE: Colorectal Cancer Liquid Biopsy Screening for Molecularly Assigned Therapy
COMPOSE Study (Neuroendocrine Tumors)
Coping Together-2 (Cancer Support)
D3-002: A Study to Evaluate ETC-1922159 in Advanced Solid Tumors
DKN-01 in Combination with Tislelizumab ± Chemotherapy in Patients with Gastric Cancer
Domvanalimab and zimberelimab versus nivolumab in gastroesophageal cancer (STAR-221)
Duke Gastric and Gastroesophageal Junction Cancer Patient Registry
EA2183: Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)
ECOG-ACRIN EAY131 (Solid Tumors, Lymphoma, or Multiple Myeloma)
Etigilimab with Nivolumab in Locally Advanced or Metastatic Solid Tumors
Expanded Access: MRTX849
FEATURES OF PRIMARY AND ADAPTIVE IMMUNOTHERAPY RESISTANCE IN MICROSATELLITE INSTABLE CANCERS
GRECO-2: GC4711 + SBRT for pancreatic cancer
Hepatic resection for metastatic pancreatic cancers
MEM-288 (solid tumors)
MOUNTAINEER-03 (Colorectal Cancer)
Multi-Kinase Inhibitor with or without Atezolizumab in Previously Treated Liver Cancer
NIT-110 (Solid tumors)
NRG-GI008 Colon Cancer
NUC-3373 for colorectal cancer
OncoCHAT (Advanced Solid Cancer)
Panitumumab Rechallenge versus Standard Therapy for RAS Wild-Type Colorectal Cancer
Pembrolizumab plus lenvatinib and belzutifan for specified solid tumors
Phase 2 Chemo with or without Hepatic Artery Infusion for IHCC (Cholangiocarcinoma)
Precision Medicine mCRC (Liver Cancer)
PT-112 in mCRPC (Prostate Cancer)
Relatlimab-nivolumab versus regorafenib or trifluridine + tipiracil for colorectal cancer
SGNTUC-024 (HER2+ Gastrointestinal Cancers)
Stool collection study for cancer patients treated with irinotecan-based therapy
Study of drugs Targeting Mitogen-Activated Protein Kinase Pathway in Gastrointestinal Cancer
Synthekine STK-012 (Solid Tumors)
Talimogene Laherparepvec in Peritoneal Surface Malignancies
TCR2-18-01_gavo-cel (Mesothelin-Expressing Cancers)
The 3PC Trial (Intraductal Papillary Mucinous Neoplasm)
The Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer (Intrinsic)
Therapeutic vaccines and an immune checkpoint inhibitor for stage IV colorectal cancer
Tucatinib, trastuzumab, ramucirumab, and paclitaxel in HER2+ gastroesophageal cancer